|
Woodcock: Industry Collaborations Can Save Time, Boost Profits
Drug sponsors should look to their peers as potential partners, not as competitors, if they want to create a more effective and efficient path to cancer drug discovery, CDER Director Janet Woodcock advises.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives